C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61P 31/04 (2006.01) C07D 401/12 (2006.01)
Patent
CA 2608634
Novel N-formyl hydroxylamine compounds (I) and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes . The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed. wherein R1 is hydrogen, alkyl, heteroalkyi, heterocycloalkyl, aryl or heteroaryl.; R3 is hydrogen, halogen, or alkoxy; R4 is aryl, or heteroaryl; or n is 0 to 3 and provided that R1 is cycloalkyl and/or R4 is an optionally substituted 6 membered, monocyclic heteroaryl ring having 2, 3 or 4 nitrogen heteroatoms in the ring wherein one or more of the ring nitrogen heteroatoms is optionally oxidized.
L'invention concerne des nouveaux composés de N-formylhydroxylamine et leurs dérivés. Ces composés de N-formylhydroxylamine inhibent la peptidyle déformylase (PDF), une enzyme présente dans les procaryotes. Ces composés sont utiles en tant qu'antimicrobiens et qu'antibiotiques. Les composés de l'invention présentent une inhibition sélective de la peptidyle déformylase contre d'autres métalloprotéinases de type MMP. L'invention concerne également des méthodes de préparation et d'utilisation desdits composés.
Bracken Kathryn Rene
Bushell Simon
Dean Karl
Francavilla Charles
Jain Rakesh K.
Fetherstonhaugh & Co.
Novartis Ag
Vicuron Pharmaceuticals Inc.
LandOfFree
N-formyl hydroxylamine compounds as pdf inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-formyl hydroxylamine compounds as pdf inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-formyl hydroxylamine compounds as pdf inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1575824